Does TORSEMIDE Cause Nephrolithiasis? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Nephrolithiasis have been filed in association with TORSEMIDE (Torsemide). This represents 0.1% of all adverse event reports for TORSEMIDE.
11
Reports of Nephrolithiasis with TORSEMIDE
0.1%
of all TORSEMIDE reports
3
Deaths
10
Hospitalizations
How Dangerous Is Nephrolithiasis From TORSEMIDE?
Of the 11 reports, 3 (27.3%) resulted in death, 10 (90.9%) required hospitalization, and 10 (90.9%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORSEMIDE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TORSEMIDE Cause?
General physical health deterioration (1,233)
Dyspnoea (1,176)
Acute kidney injury (975)
Dizziness (870)
Oedema peripheral (823)
Fall (707)
Dehydration (705)
Cardiac failure (698)
Hypotension (689)
Fatigue (635)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which TORSEMIDE Alternatives Have Lower Nephrolithiasis Risk?
TORSEMIDE vs TOVIAZ
TORSEMIDE vs TOVORAFENIB
TORSEMIDE vs TOZINAMERAN
TORSEMIDE vs TRABECTEDIN
TORSEMIDE vs TRACLEER